Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Gov’t approves millions for border cities in North under Hezbollah fire - 2What is ‘Auld Lang Syne’? Why we sing this song at midnight on New Year’s Eve.
- 3Top Pastry: What's Your Sweet Treat of Decision?
- 4The Quadrantid meteor shower peaks tonight, but will the full 'Wolf Moon' outshine the show?
- 5Energy security rifts widen in Europe
- Skeleton of famed musketeer possibly found in Dutch church
- 'Set up an Army Radio station at President’s Residence': Source close to Katz slams Herzog
- 7 Methods for further developing Rest Quality
- Novo Nordisk gears up for December Ozempic launch in India, sources say
- Finding China: Four Urban areas for a Remarkable Excursion
- Greenland’s melting ice and landslide-prone fjords make the oil and minerals Trump is eyeing dangerous to extract
- The Ascent of Robots: Occupations That Man-made brainpower Might Dispense with
- Vaccine exemptions for religious or personal beliefs are rising across the U.S.
- ‘This year nearly broke me as a scientist’ – US researchers reflect on how 2025’s science cuts have changed their lives
